UK Authorizes Vertex’s Casgevy, The World’s First CRISPR/Cas9 Gene Therapy

Vertex’s Casgevy has made history as the world’s first approved CRISPR gene editing therapy after the UK’s MHRA authorized the medicine ahead of its US and European regulatory counterparts.